FDA approves migraine drug

Aimovig

A new FDA approved drug designed to fight chronic migraine attacks could be on the market within a week.

Aimovig is designed to reduce the frequency of migraines that affect about 12 percent of Americans.

The drug works by blocking the activity of a genetic molecule involved in migraine attacks.

Patients will be able to administer Aimovig through monthly injections at home.

The drug requires a prescription and it's expected to come with a price tag of $575 a month.

close video ad
Unmutetoggle ad audio on off

Trending